|
|
Other links at Articles > HIV/AIDS |
| 2. |
Bone Loss With Anti-HIV Agents Not Dependent on Regimen
|
|
|
Independently of the regime employed, initiation of antiretroviral therapy causes a reduction in bone mineral density (BMD) in HIV-infected patients, researchers report in the August issue of the Journal of Acquired Immune Deficiency Syndromes. Reuters Health Information
|
| 3. |
HIV Multidrug Treatment Failures on the Decline
|
|
|
Although mortality rates remain high for HIV-infected patients who fail at least two regimens, new research indicates that multidrug treatment failures have decreased markedly over the last decade. Reuters Health Information
|
| 4. |
Akt Inhibitors Target HIV-Infected Macrophages
|
|
|
Akt inhibitors, including miltefosine, promote cell death of HIV-infected macrophages without harming uninfected cells, according to a report in the January 31st issue of Retrovirology. Reuters Health Information
|
|
|